Peer-reviewedCC BY 4.0JACC: CardioOncology
Fatal Coronary and Mesenteric Vasculopathy With Immune Checkpoint Inhibitor Therapy
- 1Division of Cardiovascular Medicine, University of Utah, Salt Lake City, Utah, USA
- 2Department of Pathology, University of Utah, Salt Lake City, Utah, USA
Related
- Safety of concurrent immune checkpoint inhibitor therapy during postoperative radiotherapy for triple-negative breast cancer: A preliminary retrospective analysis
- Concurrent Immune-related Enteritis and Cytomegalovirus Enteritis during Immune Checkpoint Inhibitor Therapy
- Immune Checkpoint Inhibitor Therapy Triggers Autoimmune Cerebellar Ataxia with Anti-P/Q-type VGCC Antibody and Anti-mGluR5 Antibodies: A Case Report
- Ferroptosis-driven radio-immunosensitization: an emerging mechanistic framework for enhancing response to immune checkpoint inhibitor therapy
- Absence of Viable Tumor Cells in Macroscopically Pigmented Regional Lymph Nodes after Immune Checkpoint Inhibitor Therapy in Duodenal Metastasis of Cutaneous Melanoma: A Case Report.
BibTeX
@article{abrahamowicz2026fatal,
title = {{Fatal Coronary and Mesenteric Vasculopathy With Immune Checkpoint Inhibitor Therapy}},
author = {Aleksandra Abrahamowicz and Roberta Florido and Drew Ferguson and Fred Clayton and Monica P. Revelo and Anees Daud},
journal = {JACC: CardioOncology},
year = {2026},
month = oct,
doi = {10.1016/j.jaccao.2026.09.008},
url = {https://doi.org/10.1016/j.jaccao.2026.09.008},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Fatal Coronary and Mesenteric Vasculopathy With Immune Checkpoint Inhibitor Therapy
AU - Aleksandra Abrahamowicz
AU - Roberta Florido
AU - Drew Ferguson
AU - Fred Clayton
AU - Monica P. Revelo
AU - Anees Daud
PY - 2026
DA - 2026/10/01
JO - JACC: CardioOncology
DO - 10.1016/j.jaccao.2026.09.008
UR - https://doi.org/10.1016/j.jaccao.2026.09.008
SN - 2666-0873
ER -